Ngā hua rapu - Watson, Drew
- E whakaatu ana i te 1 - 12 hua o te 12
-
1
Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX(® )Colon Cancer Assay mā Clark-Langone, Kim M, Sangli, Chithra, Krishnakumar, Jayadevi, Watson, Drew
I whakaputaina 2010Text -
2
-
3
Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and N... mā Mamounas, Eleftherios P., Tang, Gong, Fisher, Bernard, Paik, Soonmyung, Shak, Steven, Costantino, Joseph P., Watson, Drew, Geyer, Charles E., Wickerham, D. Lawrence, Wolmark, Norman
I whakaputaina 2010Text -
4
Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies mā Knezevic, Dejan, Goddard, Audrey D, Natraj, Nisha, Cherbavaz, Diana B, Clark-Langone, Kim M, Snable, Jay, Watson, Drew, Falzarano, Sara M, Magi-Galluzzi, Cristina, Klein, Eric A, Quale, Christopher
I whakaputaina 2013Text -
5
Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant... mā O'Connell, Michael J., Lavery, Ian, Yothers, Greg, Paik, Soonmyung, Clark-Langone, Kim M., Lopatin, Margarita, Watson, Drew, Baehner, Frederick L., Shak, Steven, Baker, Joffre, Cowens, J. Wayne, Wolmark, Norman
I whakaputaina 2010Text -
6
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients mā Habel, Laurel A, Shak, Steven, Jacobs, Marlena K, Capra, Angela, Alexander, Claire, Pho, Mylan, Baker, Joffre, Walker, Michael, Watson, Drew, Hackett, James, Blick, Noelle T, Greenberg, Deborah, Fehrenbacher, Louis, Langholz, Bryan, Quesenberry, Charles P
I whakaputaina 2006Text -
7
Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival mā Yang, Joshua Y.C., Verleden, Stijn E., Zarinsefat, Arya, Vanaudenaerde, Bart M., Vos, Robin, Verleden, Geert M., Sarwal, Reuben D., Sigdel, Tara K., Liberto, Juliane M., Damm, Izabella, Watson, Drew, Sarwal, Minnie M.
I whakaputaina 2019Text -
8
A Novel Multi-Biomarker Assay for Non-Invasive Quantitative Monitoring of Kidney Injury mā Watson, Drew, Yang, Joshua Y. C., Sarwal, Reuben D., Sigdel, Tara K., Liberto, Juliane M., Damm, Izabella, Louie, Victoria, Sigdel, Shristi, Livingstone, Devon, Soh, Katherine, Chakraborty, Arjun, Liang, Michael, Lin, Pei-Chen, Sarwal, Minnie M.
I whakaputaina 2019Text -
9
Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-naïve, newly diagnosed patients with non-small cell lung cancer mā Chen, Yen-Lin, Huang, Wen-Chien, Lin, Feng-Ming, Hsieh, Huangpin B., Hsieh, Chia-Hsun, Hsieh, Ruey Kuen, Chen, Kuo-Wei, Yen, Ming-Hong, Lee, James, Su, Stephen, Marfatia, Twinkal, Chang, Shih-En, Sundar, Padma, Patterson, Bruce, Watson, Drew, Mei, Rui, Javey, Manana
I whakaputaina 2019Text -
10
Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer mā Tsai, Wen-Sy, You, Jeng-Fu, Hung, Hsin-Yuan, Hsieh, Pao-Shiu, Hsieh, Ben, Lenz, Heinz-Josef, Idos, Gregory, Friedland, Shai, Yi-Jiun Pan, Jennifer, Shao, Hung-Jen, Wu, Jen-chia, Lai, Jr-Ming, Chang, Shih-En, Mei, Rui, Watson, Drew, Javey, Manana, Nimgaonkar, Ashish
I whakaputaina 2019Text -
11
Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer mā Kim, Chungyeul, Tang, Gong, Pogue-Geile, Katherine L., Costantino, Joseph P., Baehner, Frederick L., Baker, Joffre, Cronin, Maureen T., Watson, Drew, Shak, Steven, Bohn, Olga L., Fumagalli, Debora, Taniyama, Yusuke, Lee, Ahwon, Reilly, Megan L., Vogel, Victor G., McCaskill-Stevens, Worta, Ford, Leslie G., Geyer, Charles E., Wickerham, D. Lawrence, Wolmark, Norman, Paik, Soonmyung
I whakaputaina 2011Text -
12
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myelo... mā Ching, Travers, Duncan, Megan E., Newman-Eerkes, Tera, McWhorter, Mollie M. E., Tracy, Jeffrey M., Steen, Michelle S., Brown, Ryan P., Venkatasubbarao, Srivatsa, Akers, Nicholas K., Vignali, Marissa, Moorhead, Martin E., Watson, Drew, Emerson, Ryan O., Mann, Tobias P., Cimler, B. Melina, Swatkowski, Pamela L., Kirsch, Ilan R., Sang, Charles, Robins, Harlan S., Howie, Bryan, Sherwood, Anna
I whakaputaina 2020Text